540788 — Aspira Pathlab & Diagnostics Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹706.82m
- IN₹719.16m
- IN₹219.99m
- 64
- 26
- 56
- 47
Annual cashflow statement for Aspira Pathlab & Diagnostics, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 13.8 | 44.6 | -0.887 | -26.7 | 20.2 |
| Depreciation | |||||
| Non-Cash Items | 9.15 | 7.61 | 2.17 | 2.31 | 2.81 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 19.3 | -48.3 | -17.3 | 19.6 | -19.7 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 56.7 | 20.3 | -0.12 | 10.5 | 18.3 |
| Capital Expenditures | -2.96 | -6.07 | -1.36 | -2.63 | -3.44 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 2.04 | 0.947 | 2.96 | 4.01 | 4.6 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.919 | -5.12 | 1.59 | 1.38 | 1.16 |
| Financing Cash Flow Items | -8.91 | -3.73 | -4.17 | -3.68 | -3.47 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -21.7 | -13.5 | -9.35 | -9.54 | -9.94 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 34.1 | 1.67 | -7.88 | 2.37 | 9.49 |